Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters.

BACKGROUND The effectiveness of ABC has been traditionally measured as the reduction in internal margin (IM) within the planning target volume (PTV). Not to overestimate the benefit of ABC, the effect of patient movement during treatment also needs to be taken into account. We determined the IM and set-up error with ABC and the effect on physical lung parameters compared to standard margins used with free breathing. We also assessed interfraction oesophageal movement to determine a planning organ at risk volume (PRV). MATERIALS AND METHODS Two sequential studies were performed using ABC in NSCLC patients suitable for radical radiotherapy (RT). Twelve out of 14 patients in Study 1 had tumours visible fluoroscopically and had intrafraction tumour movement assessed with and without ABC. Sixteen patients were recruited to Study 2 and had interfraction tumour movement measured using ABC in a moderate deep inspiration breath-hold, of these 7 patients also had interfraction oesophageal movement recorded. Interfraction movement was assessed by CT scan prior to and in the middle and final week of RT. Displacement of the tumour centre of mass and oesophageal borders relative to the first scan provided a measure of movement. Set-up error was measured in 9 patients treated with an in-house lung board adapted for the ABC device. Combining movement and set-up errors determined PTV and PRV margins with ABC. The effect of ABC on mean lung dose (MLD), lung V20 and V13 was calculated. RESULTS ABC in a moderate deep inspiration breath-hold was tolerated in 25 out of 30 patients (83%) in Study 1 and 2. The random contribution of periodic tumour motion was reduced by 90% in the y direction with ABC compared to free-breathing. The magnitude of motion reduction was less in the x and z direction. Combining the systematic and random set-up error in quadrature with the systematic and random intrafraction and interfraction tumour variations with ABC results in a PTV margin of 8.3mm in the x direction, 12.0mm in the y direction and 9.8mm in the z direction. There was a relative mean reduction in MLD, lung V20 and V13 of 25%, 21% and 18% with the ABC PTV compared to a free-breathing PTV. Oesophageal movement combined with set-up error resulted in an isotropic PRV of 4.7 mm. CONCLUSIONS The reduction in PTV size with ABC resulted in an 18-25% relative reduction in physical lung parameters. PTV margin reduction has the potential to spare normal lung and allow dose-escalation if coupled with image-guided RT. The oesophageal PRV needs to be considered when irradiating central disease and is of increasing importance with altered RT fractionation and concomitant chemoradiation schedules. Further reductions in PTV and PRV may be possible if patient set-up error was minimised, confirming that attention to patient immobilisation is as important as attempts to control tumour motion.

[1]  C. Perez,et al.  Impact of tumor control on survival in carcinoma of the lung treated with irradiation. , 1986, International journal of radiation oncology, biology, physics.

[2]  J. Wong,et al.  The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.

[3]  S. Kudoh,et al.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  N. O'Rourke,et al.  Concurrent chemoradiotherapy in non-small cell lung cancer. , 2010, The Cochrane database of systematic reviews.

[5]  S Senan,et al.  An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer. , 1999, International journal of radiation oncology, biology, physics.

[6]  K. Forster,et al.  The relationship between local dose and loss of function for irradiated lung. , 2003, International journal of radiation oncology, biology, physics.

[7]  Achim Schweikard,et al.  Respiration tracking in radiosurgery. , 2004, Medical physics.

[8]  J Hanson,et al.  Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration. , 2001, International journal of radiation oncology, biology, physics.

[9]  M. Herk Errors and margins in radiotherapy. , 2004 .

[10]  H. Groen,et al.  Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[12]  R K Ten Haken,et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.

[13]  O. Brodin,et al.  Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .

[14]  A Harvey,et al.  Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Marcel van Herk,et al.  Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[17]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[18]  E. Vokes,et al.  Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies. , 1999, Oncology.

[19]  P. Remeijer,et al.  Set-up verification using portal imaging; review of current clinical practice. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  John W Wong,et al.  Validation of active breathing control in patients with non-small-cell lung cancer to be treated with CHARTWEL. , 2003, International journal of radiation oncology, biology, physics.

[21]  Jan-Jakob Sonke,et al.  Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. , 2006, International journal of radiation oncology, biology, physics.

[22]  Marcel van Herk,et al.  Margins for geometric uncertainty around organs at risk in radiotherapy. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Y. Ung,et al.  Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis. , 2004, International journal of radiation oncology, biology, physics.

[24]  B. Murray,et al.  Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices. , 1999, International journal of radiation oncology, biology, physics.

[25]  E. Yorke,et al.  Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatment. , 2004, Seminars in radiation oncology.

[26]  M. Socinski,et al.  Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  Y. Ung,et al.  Reproducibility of lung tumor position and reduction of lung mass within the planning target volume using active breathing control (ABC). , 2003, International journal of radiation oncology, biology, physics.

[28]  S. Senan,et al.  2158 An analysis of anatomic landmark mobility and setup errors in radiotherapy for lung cancer , 1997 .

[29]  Harry Keller,et al.  Application of the spirometer in respiratory gated radiotherapy. , 2003, Medical physics.

[30]  D Verellen,et al.  Electronic portal imaging with on-line correction of setup error in thoracic irradiation: clinical evaluation. , 1998, International journal of radiation oncology, biology, physics.

[31]  P. Evans,et al.  Effects of averaging over motion and the resulting systematic errors in radiation therapy , 2006, Physics in medicine and biology.

[32]  Joos V Lebesque,et al.  Inclusion of geometric uncertainties in treatment plan evaluation. , 2002, International journal of radiation oncology, biology, physics.

[33]  David Sarrut,et al.  Nonrigid registration method to assess reproducibility of breath-holding with ABC in lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[34]  Ladislav Pecen,et al.  Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. , 2004, Lung cancer.

[35]  Douglas L. Jones ICRU Report 50—Prescribing, Recording and Reporting Photon Beam Therapy , 1994 .